Skip to Main Content

Paper Details

Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease.
Ann Neurol
10
2022
Author NameAffiliation
Thomas D BirdUniversity of Washington
Sandra E BlackSunnybrook Research Institute, University of Toronto
Martin R FarlowIndiana University School of Medicine
Nick C FoxUCL Queen Square Institute of Neurology, University College London
Lawrence S HonigTaub Institute, Columbia University Irving Medical Center
Ging-Yuek R HsiungUniversity of British Columbia
Clifford R JackMayo Clinic
Eric McDadeWashington University School of Medicine
Stephen SallowayAlpert Medical School of Brown University, Butler Hospital
David B CliffordWashington University School of Medicine
  • 1 - 10

Datasets

Release 1.2